Pancreatic adenocarcinoma in a young patient population - 12-Year experience at Memorial Sloan Kettering Cancer Center

Journal of Surgical Oncology

Volumn 100, Issue 1, 2009, Pages 8-12

  Duffy, A ^a   Capanu, M ^a   Allen, P ^a   Kurtz, R ^a   Olson, S H ^a   Ludwig, E ^a   Klimstra, D S ^a   O'Reilly, E M ^a,b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Gastrointestinal Oncology Solid Tumor Service   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cancer; Pancreatic; Young

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS BIOPSY; PRIORITY JOURNAL; SMOKING HABIT; ADENOCARCINOMA; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 67649407563     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21292     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Loos M, Kleeff J, Friess H, et al.: Surgical treatment of pancreatic cancer. Ann NY Acad Sci 2008;1138:169-180.
3. Moore MJ, Goldstein D, Hamm J, et al.: Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007;25:1960-1966. (Pubitemid 46972777)
4. Gawron AJ, Gapstur SM, Fought AJ, et al.: Sociodemographic and tumor characteristics associated with pancreatic cancer surgery in the United States. J Surg Oncol 2008;97:578-582. (Pubitemid 351794146)
5. Ferrone CR, Brennan MF, Gonen M, et al.: Pancreatic adenocarcinoma: The actual 5-year survivors. J Gastrointest Surg 2008;12:701-706.
6. Baxter NN, Whitson BA, Tuttle TM: Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol 2007;14:1320-1326. (Pubitemid 46536816)
7. Regine WF, Winter KA, Abrams RA, et al.: Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial. JAMA 2008;299:1019-1026. (Pubitemid 351347058)
8. Oettle H, Post S, Neuhaus P, et al.: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007;297:267-277. (Pubitemid 46143304)
9. Zhang J, Dhakal I, Yan H, et al.: Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973-2002. Ann Oncol 2007;18:1268-1279.
10. Luttges J, Stigge C, Pacena M, et al.: Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years. Cancer 2004;100:173-182.
11. Bergmann F, Aulmann S, Wente MN, et al.: Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40. J Clin Pathol 2006;59:580-584. (Pubitemid 43886040)
12. Soliman AS, El-Ghawalby N, Ezzat F, et al.: Unusually high rate of young-onset pancreatic cancer in the East Nile Delta region of Egypt. Int J Gastrointest Cancer 2002;32:143-151. (Pubitemid 36749003)
13. Hruban RH, van Mansfeld AD, Offerhaus GJ, et al.: K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutantenriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-554. (Pubitemid 24058210)
14. Almoguera C, Shibata D, Forrester K, et al.: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988;53:549-554.
15. Matsuno S, Egawa S, Fukuyama S, et al.: Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 2004;28:219-230. (Pubitemid 38437313)
16. Enayati PG, Traverso LW: Pancreatic cancer and comparison of a hospital-based tumor registry with a National Cancer Data Base. Am J Surg 1997;173:436-440. (Pubitemid 27231501)
17. Silverman DT, Dunn JA, Hoover RN, et al.: Cigarette smoking and pancreas cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1994;86:1510-1516. (Pubitemid 24330214)
18. Mack TM, Yu MC, Hanisch R, et al.: Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 1986;76:49-60. (Pubitemid 16156103)
19. Duell EJ, Holly EA, Bracci PM, et al.: A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst 2002;94:297-306. (Pubitemid 34196324)
20. Falk RT, Pickle LW, Fontham ET, et al.: Life-style risk factors for pancreatic cancer in Louisiana: A case-control study. Am J Epidemiol 1988;128:324-336. (Pubitemid 18181504)
21. Farrow DC, Davis S: Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer 1990;45:816-820. (Pubitemid 20179628)
22. Howe GR, Jain M, Burch JD, et al.: Cigarette smoking and cancer of the pancreas: Evidence from a population-based case-control study in Toronto, Canada. Int J Cancer 1991;47:323-328.
23. Hassan MM, Bondy ML, Wolff RA, et al.: Risk factors for pancreatic cancer: Case-control study. Am J Gastroenterol 2007; 102:2696-2707. (Pubitemid 350179330)
24. Gandini S, Lowenfels AB, Jaffee EM, et al.: Allergies and the risk of pancreatic cancer: A meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev 2005;14:1908-1916. (Pubitemid 41161199)
25. Nothlings U, Wilkens LR, Murphy SP, et al.: Meat and fat intake as risk factors for pancreatic cancer: The multiethnic cohort study. J Natl Cancer Inst 2005;97:1458-1465. (Pubitemid 41520081)
26. Olsen GW, Mandel JS, Gibson RW, et al.: A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. Am J Public Health 1989;79:1016-1019. (Pubitemid 19207435)
27. Lin Y, Kikuchi S, Tamakoshi A, et al.: Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer 2007;120:2665-2671. (Pubitemid 46651289)
28. Eppel A, Cotterchio M, Gallinger S: Allergies are associated with reduced pancreas cancer risk: A population-based case-control study in Ontario, Canada. Int J Cancer 2007;121:2241-2245. (Pubitemid 47585604)
29. Del Chiaro M, Zerbi A, Falconi M, et al.: Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology 2007;7:459-469. (Pubitemid 47587625)
30. Ekbom A, McLaughlin JK, Karlsson BM, et al.: Pancreatitis and pancreatic cancer: A population-based study. J Natl Cancer Inst 1994;86:625-627. (Pubitemid 24143173)
31. Adams AL, Siegal GP, Jhala NC: Solid pseudopapillary tumor of the pancreas: A review of salient clinical and pathologic features. Adv Anat Pathol 2008;15:39-45. (Pubitemid 351627652)
32. Chen SQ, Zou SQ, Dai QB, et al.: Clinical analysis of solidpseudopapillary tumor of the pancreas: Report of 15 cases. Hepatobiliary Pancreat Dis Int 2008;7:196-200.
33. Klimstra DS, Wenig BM, Adair CF, et al.: Pancreatoblastoma. A clinicopathologic study and review of the literature. Am J Surg Pathol 1995;19:1371-1389.
34. Sener SF, Fremgen A, Menck HR, et al.: Pancreatic cancer: A report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999;189:1-7.
35. Cengiz M, Zorlu F, Yalcin S, et al.: Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Med Oncol 2007;24:239-243. (Pubitemid 350135977)
36. Duffy A, Kortmansky J, Schwartz GK, et al.: A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. Ann Oncol 2008;19:86-91.